Literature DB >> 31378248

50-Year-Old Man With Dyspnea on Exertion, Orthopnea, and Weight Gain.

Sae K Jang1, Megha Prasad1, LaPrincess C Brewer2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31378248      PMCID： PMC7265175          DOI： 10.1016/j.mayocp.2018.12.038

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN： 0025-6196            Impact factor:   7.616


× No keyword cloud information.
  15 in total

1.  A comparison of rate control and rhythm control in patients with atrial fibrillation.

Authors:  D G Wyse; A L Waldo; J P DiMarco; M J Domanski; Y Rosenberg; E B Schron; J C Kellen; H L Greene; M C Mickel; J E Dalquist; S D Corley
Journal:  N Engl J Med       Date:  2002-12-05       Impact factor: 91.245

2.  Persistent left ventricular dilatation in tachycardia-induced cardiomyopathy patients after appropriate treatment and normalization of ejection fraction.

Authors:  Gopi Dandamudi; Abbas Y Rampurwala; Jothiharan Mahenthiran; John M Miller; Mithilesh K Das
Journal:  Heart Rhythm       Date:  2008-05-02       Impact factor: 6.343

3.  2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society.

Authors:  Craig T January; L Samuel Wann; Joseph S Alpert; Hugh Calkins; Joaquin E Cigarroa; Joseph C Cleveland; Jamie B Conti; Patrick T Ellinor; Michael D Ezekowitz; Michael E Field; Katherine T Murray; Ralph L Sacco; William G Stevenson; Patrick J Tchou; Cynthia M Tracy; Clyde W Yancy
Journal:  Circulation       Date:  2014-03-28       Impact factor: 29.690

4.  Risk factors for congestive heart failure in US men and women: NHANES I epidemiologic follow-up study.

Authors:  J He; L G Ogden; L A Bazzano; S Vupputuri; C Loria; P K Whelton
Journal:  Arch Intern Med       Date:  2001-04-09

Review 5.  Rhythm control in atrial fibrillation.

Authors:  Jonathan P Piccini; Laurent Fauchier
Journal:  Lancet       Date:  2016-08-20       Impact factor: 79.321

6.  Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial.

Authors:  Philip A Poole-Wilson; Karl Swedberg; John G F Cleland; Andrea Di Lenarda; Peter Hanrath; Michel Komajda; Jacobus Lubsen; Beatrix Lutiger; Marco Metra; Willem J Remme; Christian Torp-Pedersen; Armin Scherhag; Allan Skene
Journal:  Lancet       Date:  2003-07-05       Impact factor: 79.321

Review 7.  Tachycardia-induced cardiomyopathy.

Authors:  Ernesto Umana; C Arturo Solares; Martin A Alpert
Journal:  Am J Med       Date:  2003-01       Impact factor: 4.965

8.  Tachycardia-induced heart failure.

Authors:  Jitenbhai J Patel; Charles T Whittaker
Journal:  Perm J       Date:  2007

Review 9.  Carvedilol in the treatment of chronic heart failure: lessons from the Carvedilol Or Metoprolol European Trial.

Authors:  Britt Kveiborg; Atheline Major-Petersen; Buris Christiansen; Christian Torp-Pedersen
Journal:  Vasc Health Risk Manag       Date:  2007

Review 10.  Pathophysiology, diagnosis and treatment of tachycardiomyopathy.

Authors:  Claire A Martin; Pier D Lambiase
Journal:  Heart       Date:  2017-08-30       Impact factor: 5.994
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.